Search Results
You are looking at 1 - 2 of 2 items for
- Author: J Epelbaum x
- Refine by access: All content x
Search for other papers by F Mounier in
Google Scholar
PubMed
Search for other papers by E Pellegrini in
Google Scholar
PubMed
Search for other papers by C Kordon in
Google Scholar
PubMed
Search for other papers by J Epelbaum in
Google Scholar
PubMed
Search for other papers by M T Bluet-Pajot in
Google Scholar
PubMed
Involvement of endogenous corticotropin releasing hormone (CRH) in the regulation of spontaneous growth hormone (GH) secretion was investigated. A CRH antagonist, α helical CRH 9–41, was intracerebroventricularly infused for 36 h at a rate of 1 μg/0·5 μl/h to freely moving, cannulated adult male rats. Serial blood samples were drawn every 20 min for the last 8 hours of α helical CRH 9–41 infusion. The treatment induced a marked increase in GH peak amplitude without affecting either trough levels or numbers of peaks. In parallel, levels of growth hormone releasing hormone (GHRH) mRNA in the arcuate nucleus, but not of somatotropin release inhibiting hormone (SRIH) mRNA in the periventricular and arcuate nuclei, were increased. These data suggest that, in addition to its action in the stress-induced inhibition of GH secretion through regulation of periventricular SRIH neurons, CRH can also act as a modulator of endogenous GH secretion through regulation of arcuate GHRH neurons. Whether the modulatory effects of CRH on GHRH neurons are direct or indirect remains to be established.
Journal of Endocrinology (1997) 152, 431–436
Search for other papers by J. N. Hugues in
Google Scholar
PubMed
Search for other papers by A. Enjalbert in
Google Scholar
PubMed
Search for other papers by E. Moyse in
Google Scholar
PubMed
Search for other papers by C. Shu in
Google Scholar
PubMed
Search for other papers by M. J. Voirol in
Google Scholar
PubMed
Search for other papers by J. Sebaoun in
Google Scholar
PubMed
Search for other papers by J. Epelbaum in
Google Scholar
PubMed
ABSTRACT
The role of somatostatin (SRIF) on adenohypophysial hormone secretion in starved rats was reassessed by passive immunization. Because of the absence of pulsatile GH secretion in starved rats, the effects of the injection of SRIF antiserum on GH levels can be clearly demonstrated. To determine whether starvation modifies the sensitivity of the adenohypophysis to SRIF, we measured 125I-labelled iodo-N-Tyr-SRIF binding. There was no difference in the dissociation constant (K d) nor in the maximal binding capacity (Bmax) in fed (n = 15) and starved (n = 15) animals (K d = 0·38 ± 0·09 (s.e.m.) and 0·45 ± 0·09 nmol; Bmax = 204 ± 39 and 205 ± 30 fmol/mg protein respectively).
Administration of SRIF antiserum resulted in a dose-dependent increase in plasma concentrations of GH, TSH and prolactin. The minimal effective dose of SRIF antiserum was 50 μl for GH, 100 μl for TSH and 200 μl for prolactin.
Our results show that: (1) starvation does not modify adenohypophysial SRIF-binding sites, (2) in starved male rats endogenous SRIF exerts a negative control on prolactin secretion in vivo and (3) sensitivity to endogenous SRIF seems to be different for each hypophysial cell type.
J. Endocr. (1986) 109, 169–174
